• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC. FREESTYLE LIBRE 14-DAY SENSOR; SENSOR, GLUCOSE, INVASIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC. FREESTYLE LIBRE 14-DAY SENSOR; SENSOR, GLUCOSE, INVASIVE Back to Search Results
Device Problems Product Quality Problem (1506); Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem Hyperglycemia (1905)
Event Date 01/17/2022
Event Type  malfunction  
Event Description
Patient ((b)(6) male with insulin-dependent type 2 diabetes) has been using freestyle libre 14-day sensors concurrently with dexcom g6 for 1 month - previously he was using only freestyle sensors.Freestyle libre readings were up to 50mg/dl or 35% off from dexcom readings.Dexcom readings appear to be most accurate based on patient's a1c (vs.Dexcom estimated a1c), office readings, and clinical data published.Alternatively, freestyle libre sensors do not appear to correlate to patient's bg readings or a1c, despite being used according to manufacturer labeling.In some cases, libre reported blood sugars <100mg/dl when patient's actual bg was 150mg/dl.This has caused the patient to struggle with self-monitoring and he now has little trust in any devices.He also does not trust his providers (endocrinologist, nurses, pharmacists, etc.) as they recommended these devices to him and to other patients despite these problems.Prior to starting the libre in (b)(6) 2020, his a1c was 8.2%.While on the libre, his a1c elevated to a highest recorded value of 10.2% (b)(6) 2020, and never returned to 8.2% or lower until after starting on the dexcom g6 in (b)(6) 2022.He has requested this report be filed with the fda for review of the freestyle libre 14-day system as "the squeaky wheel gets the grease".Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 14-DAY SENSOR
Type of Device
SENSOR, GLUCOSE, INVASIVE
Manufacturer (Section D)
ABBOTT DIABETES CARE INC.
MDR Report Key13315170
MDR Text Key284459383
Report NumberMW5106851
Device Sequence Number1
Product Code MDS
UDI-Device Identifier57599-0001-01
UDI-Public57599-0001-01
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 01/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/20/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
DEXCOM G6
Patient Age69 YR
Patient SexMale
Patient Weight119 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-